Five Below (FIVE)
NASDAQConsumer DiscretionarySpecialty RetailSnapshot 2026-09-04
NASDAQConsumer DiscretionarySpecialty RetailSnapshot 2026-09-04
Research Workspace
Put FIVE beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Consumer Discretionary is in expansion. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar under pressure — EPS near $8.82 in 2026: FY26 EPS guidance $8.82 vs $8.82 target.
View ThesisManagement screens strong on capital allocation, the balance sheet, market reaction to earnings.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationModerate volatility — typically moves about 2% a day.
View RiskFive Below's growth depends on strong sales and earnings guidance. The company raised its full-year revenue outlook to $5.67 billion. It also lifted adjusted EPS guidance to $10.07. Five Below trades at 31× P/E versus a peer median of 15×. This suggests the price reflects modest growth expectations. If Five Below cuts guidance, it could hurt the stock. Our read is provisional.
Trailing returns as of 2026-09-04. FIVE is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 25 analysts currently covering FIVE (as of Sep 2026).
Based on 15 Wall Street analysts offering 12-month price targets for FIVE in the last 4 months.
Continue this research
Compare FIVE with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Free account required to save the handoff. No credit card.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| FIVE Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 11 valuation methods, at three horizons. As of 2026-09-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Consumer Discretionary (broad) — fair value, gap to price, and forward P/E.
Our valuation methods disagree too much on this name right now. Rather than print a number we don't believe, we're holding it back until they converge.
Compare the value case
Put FIVE next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Expand store count by approximately 150 in 2026
Strategy shift aligns with store expansion goals.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-09-04. EPS is implied from price ÷ P/E. Not investment advice.
Current $252.20
The last 12 months of price, then the range of analyst 12-month targets from today’s $252.20.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Top 25% on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.

Advances: Maintain share repurchase program with up to $600 million authorization
Sales growth and repurchase program align with capital allocation goals.

Advances: Achieve $5.4B to $5.48B revenue in fiscal 2026
Q2 earnings beat supports revenue growth objective.

Advances: Achieve $5.4B to $5.48B revenue in fiscal 2026
Earnings beat and raised outlook support revenue growth objective.

Advances: Achieve $5.4B to $5.48B revenue in fiscal 2026
Strong comparable sales growth aligns with revenue targets.

Advances: Achieve $5.4B to $5.48B revenue in fiscal 2026
Record sales support revenue target for fiscal 2026.

Advances: Achieve $5.4B to $5.48B revenue in fiscal 2026
Sales and EPS guidance exceeds management's targets.

Advances: Achieve $5.4B to $5.48B revenue in 2026
Raising outlook indicates strong sales growth supporting revenue target.